How is a write-up on glomerular pressures in various types of genetically modified rats pertinent to the efficacy of rapamycin as an "anti-aging" drug?
Why do you feel that a blog, written by someone with no formal research or medical background or training, should be viewed as an authoritative source?
How is a write-up on glomerular pressures in various types of genetically modified rats pertinent to the efficacy of rapamycin as an "anti-aging" drug?
Ok... how is a write-up on glomerular pressures in various types of genetically modified rats pertinent to the efficacy of metformin as an "anti-aging" drug?
It'd be faster for you to just tell me why you feel that a blog, written by someone with no formal research or medical background or training, should be viewed as an authoritative source?
It'd be faster for you to just tell me why you feel that a blog, written by someone with no formal research or medical background or training, should be viewed as an authoritative source?
It is not authoritative, but at least there is no bias.
"I have the type of (REAL) job where I can choose how to spend my time," says Marcus.
Ok... how is a write-up on glomerular pressures in various types of genetically modified rats pertinent to the efficacy of metformin as an "anti-aging" drug?
Forgive me, it is simply one of the references in the video. You should watch it.
"I have the type of (REAL) job where I can choose how to spend my time," says Marcus.
It'd be faster for you to just tell me why you feel that a blog, written by someone with no formal research or medical background or training, should be viewed as an authoritative source?
It is not authoritative, but at least there is no bias.
I believe that you should likely reevaluate this.
He's a guy who goes by "Reason" (even in his professional life -- seriously, try to find his "real" name), and profiteers off of non-pharmaceutical therapies that have no clinical trials or backing -- or as his company likes to polish the turd, "preclinical biotechnology." You'd think that might cause a teensy bias towards a patented pharmaceutical.
It is not authoritative, but at least there is no bias.
I believe that you should likely reevaluate this.
He's a guy who goes by "Reason" (even in his professional life -- seriously, try to find his "real" name), and profiteers off of non-pharmaceutical therapies that have no clinical trials or backing -- or as his company likes to polish the turd, "preclinical biotechnology." You'd think that might cause a teensy bias towards a patented pharmaceutical.
Wait, this is the guy whose videos I'm supposed to watch?
Reason
CHIEF EXECUTIVE OFFICER
Reason is co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in the longevity industry since its earliest days, with investments including Oisin Biotechnologies and Leucadia Therapeutics. He is a long-standing and well-connected patient advocate for aging research, involved in numerous fundraising and outreach initiatives conducted by organizations such as the Methuselah Foundation and SENS Research Foundation since the early 2000s. He is also the founder and writer of Fight Aging!, a noted news and commentary website in the biotechnology community. Prior to his involvement in the biotechnology industry, Reason was a consultant in the software industry. He holds Masters degrees in Astrophysics from the University of St. Andrews and Space Physics from Rice University.
There may be something to the research itself, but this guy screams scam artist.
he/him When I go to sea, don’t fear for me. Fear for the storm.
Jessica Best, Fear for the Storm. From The Strange Case of the Starship Iris.
Wait, this is the guy whose videos I'm supposed to watch?
No no no no no. The guy you are supposed to watch is Dr. Stanfield. Stanfield has the testicles to admit when he is wrong about something. Some of his older videos are labeled "out of date". https://www.youtube.com/watch?v=iByaqfmWfHQ
"I have the type of (REAL) job where I can choose how to spend my time," says Marcus.
He's a guy who goes by "Reason" (even in his professional life -- seriously, try to find his "real" name), and profiteers off of non-pharmaceutical therapies that have no clinical trials or backing -- or as his company likes to polish the turd, "preclinical biotechnology." You'd think that might cause a teensy bias towards a patented pharmaceutical.
"Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases."
In other words, the company is funded by the rich.
"I have the type of (REAL) job where I can choose how to spend my time," says Marcus.